{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T19:40:07Z","timestamp":1741549207349,"version":"3.38.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,9]]},"DOI":"10.7759\/cureus.80299","type":"journal-article","created":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T19:00:55Z","timestamp":1741546855000},"source":"Crossref","is-referenced-by-count":0,"title":["Bleeding Complications Following Paracentesis in Patients Taking Apixaban"],"prefix":"10.7759","author":[{"given":"Sarah","family":"Van Dorin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosarie","family":"Tudas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Amarneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan","family":"Kuperman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.05.004","article-title":"Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study","volume":"7","author":"De Gottardi A","year":"2009","unstructured":"De Gottardi A, Th\u00e9venot T, Spahr L, et al.. Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. Clin Gastroenterol Hepatol. 2009, 7:906-9. 10.1016\/j.cgh.2009.05.004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7863\/ultra.14.10034","article-title":"Bleeding rate for ultrasound-guided paracentesis in thrombocytopenic patients","volume":"34","author":"Kurup AN","year":"2015","unstructured":"Kurup AN, Lekah A, Reardon ST, et al.. Bleeding rate for ultrasound-guided paracentesis in thrombocytopenic patients. J Ultrasound Med. 2015, 34:1833-8. 10.7863\/ultra.14.10034","journal-title":"J Ultrasound Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2019.04.017","article-title":"Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions-part II: recommendations: endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe","volume":"30","author":"Patel IJ","year":"2019","unstructured":"Patel IJ, Rahim S, Davidson JC, et al.. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions-part II: recommendations: endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe. J Vasc Interv Radiol. 2019, 30:1168-1184.e1. 10.1016\/j.jvir.2019.04.017","journal-title":"J Vasc Interv Radiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"149","author":"Joglar JA","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al.. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2024, 149:e1-e156. 10.1161\/CIR.0000000000001193","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel TL","year":"2020","unstructured":"Ortel TL, Neumann I, Ageno W, et al.. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020, 4:4693-738. 10.1182\/bloodadvances.2020001830","journal-title":"Blood Adv"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht557","article-title":"Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry","volume":"35","author":"Beyer-Westendorf J","year":"2014","unstructured":"Beyer-Westendorf J, Gelbricht V, F\u00f6rster K, et al.. Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry. Eur Heart J. 2014, 35:1888-96. 10.1093\/eurheartj\/eht557","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7326\/M23-3067","article-title":"Comparative effectiveness and safety of apixaban, rivaroxaban, and warfarin in patients with cirrhosis and atrial fibrillation: a nationwide cohort study","volume":"177","author":"Simon TG","year":"2024","unstructured":"Simon TG, Singer DE, Zhang Y, Mastrorilli JM, Cervone A, DiCesare E, Lin KJ. Comparative effectiveness and safety of apixaban, rivaroxaban, and warfarin in patients with cirrhosis and atrial fibrillation: a nationwide cohort study. Ann Intern Med. 2024, 177:1028-38. 10.7326\/M23-3067","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/00185787221111741","article-title":"Major bleeding after paracentesis associated with apixaban use: two case reports","volume":"58","author":"Kuperman E","year":"2023","unstructured":"Kuperman E, Hobbs RA. Major bleeding after paracentesis associated with apixaban use: two case reports. Hosp Pharm. 2023, 58:34-7. 10.1177\/00185787221111741","journal-title":"Hosp Pharm"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris PA","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research Electronic Data Capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009, 42:377-81. 10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/imj.16572","article-title":"Safety of abdominal paracentesis in hospitalised patients receiving uninterrupted therapeutic or prophylactic anticoagulants","volume":"55","author":"Raco J","year":"2025","unstructured":"Raco J, Bufalini J, Dreer J, Shah V, King L, Wang L, Evans M. Safety of abdominal paracentesis in hospitalised patients receiving uninterrupted therapeutic or prophylactic anticoagulants. Intern Med J. 2025, 55:77-83. 10.1111\/imj.16572","journal-title":"Intern Med J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2007.33253.x","article-title":"Perioperative management of anticoagulant therapy during cutaneous surgery: 2005 survey of Mohs surgeons","volume":"33","author":"Kirkorian AY","year":"2007","unstructured":"Kirkorian AY, Moore BL, Siskind J, Marmur ES. Perioperative management of anticoagulant therapy during cutaneous surgery: 2005 survey of Mohs surgeons. Dermatol Surg. 2007, 33:1189-97. 10.1111\/j.1524-4725.2007.33253.x","journal-title":"Dermatol Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.04.003","article-title":"Safety of diagnostic coronary angiography during uninterrupted therapeutic warfarin treatment","volume":"102","author":"Annala AP","year":"2008","unstructured":"Annala AP, Karjalainen PP, Porela P, Nyman K, Ylitalo A, Airaksinen KE. Safety of diagnostic coronary angiography during uninterrupted therapeutic warfarin treatment. Am J Cardiol. 2008, 102:386-90. 10.1016\/j.amjcard.2008.04.003","journal-title":"Am J Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.11.024","article-title":"2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the American College of Cardiology Clinical Expert Consensus Document Task Force","volume":"69","author":"Doherty JU","year":"2017","unstructured":"Doherty JU, Gluckman TJ, Hucker WJ, Januzzi JL Jr, Ortel TL, Saxonhouse SJ, Spinler SA. 2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the American College of Cardiology Clinical Expert Consensus Document Task Force. J Am Coll Cardiol. 2017, 69:871-98. 10.1016\/j.jacc.2016.11.024","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"Douketis JD","year":"2019","unstructured":"Douketis JD, Spyropoulos AC, Duncan J, et al.. Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant. JAMA Intern Med. 2019, 179:1469-78. 10.1001\/jamainternmed.2019.2431","journal-title":"JAMA Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00775-z","article-title":"Apixaban: a clinical pharmacokinetic and pharmacodynamic review","volume":"58","author":"Byon W","year":"2019","unstructured":"Byon W, Garonzik S, Boyd RA, Frost CE. Apixaban: a clinical pharmacokinetic and pharmacodynamic review. Clin Pharmacokinet. 2019, 58:1265-79. 10.1007\/s40262-019-00775-z","journal-title":"Clin Pharmacokinet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger CB","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, et al.. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011, 365:981-92. 10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli G","year":"2013","unstructured":"Agnelli G, Buller HR, Cohen A, et al.. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013, 369:799-808. 10.1056\/NEJMoa1302507","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-020-07065-y","article-title":"Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and liver disease: a meta-analysis and systematic review","volume":"35","author":"Huang ZC","year":"2021","unstructured":"Huang ZC, Li CQ, Liu XY, et al.. Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and liver disease: a meta-analysis and systematic review. Cardiovasc Drugs Ther. 2021, 35:1205-15. 10.1007\/s10557-020-07065-y","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2018.08.011","article-title":"Direct oral anticoagulants in patients with liver cirrhosis: a systematic review","volume":"170","author":"Hoolwerf EW","year":"2018","unstructured":"Hoolwerf EW, Kraaijpoel N, B\u00fcller HR, van Es N. Direct oral anticoagulants in patients with liver cirrhosis: a systematic review. Thromb Res. 2018, 170:102-8. 10.1016\/j.thromres.2018.08.011","journal-title":"Thromb Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.05.016","article-title":"Management of antithrombotic therapy in atrial fibrillation patients undergoing PCI: JACC state-of-the-art review","volume":"74","author":"Capodanno D","year":"2019","unstructured":"Capodanno D, Huber K, Mehran R, et al.. Management of antithrombotic therapy in atrial fibrillation patients undergoing PCI: JACC state-of-the-art review. J Am Coll Cardiol. 2019, 74:83-99. 10.1016\/j.jacc.2019.05.016","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.034722","article-title":"Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective-2018 update","volume":"138","author":"Angiolillo DJ","year":"2018","unstructured":"Angiolillo DJ, Goodman SG, Bhatt DL, et al.. Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective-2018 update. Circulation. 2018, 138:527-36. 10.1161\/CIRCULATIONAHA.118.034722","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s40477-023-00838-9","article-title":"Implementing a 3\u00a0year, longitudinal point of care ultrasound curriculum in an internal medicine residency program","volume":"27","author":"Rappaport C","year":"2024","unstructured":"Rappaport C, Schwartz A, McConomy B, Choice S, Ten Eyck P, Smock J. Implementing a 3\u00a0year, longitudinal point of care ultrasound curriculum in an internal medicine residency program. J Ultrasound. 2024, 27:123-7. 10.1007\/s40477-023-00838-9","journal-title":"J Ultrasound"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.12788\/jhm.3095","article-title":"Recommendations on the use of ultrasound guidance for adult abdominal paracentesis: a position statement of the Society of Hospital Medicine","volume":"14","author":"Cho J","year":"2019","unstructured":"Cho J, Jensen TP, Reierson K, et al.. Recommendations on the use of ultrasound guidance for adult abdominal paracentesis: a position statement of the Society of Hospital Medicine. J Hosp Med. 2019, 14:E7-E15. 10.12788\/jhm.3095","journal-title":"J Hosp Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/330192-bleeding-complications-following-paracentesis-in-patients-taking-apixaban","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T19:00:57Z","timestamp":1741546857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/330192-bleeding-complications-following-paracentesis-in-patients-taking-apixaban"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,9]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.80299","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,9]]}}}